• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number TF-21A
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 10/10/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that on an unknown date a 21mm trifecta valve was implanted in the the aortic valve.On (b)(6) 2023, a 25mm navitor valve was implanted into the trifecta valve in a valve in valve procedure.The reason for the valve in valve procedure is unknown.The patient remained hemodynamically stable during the procedure.The patient was reported stable.
 
Additional Manufacturer Narrative
An event of valve in a valve in valve procedure was reported.A more comprehensive assessment could not be performed as the device remains implanted and was not received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Event or Problem Description
N/a.
 
Additional Manufacturer Narrative
An event of navitor valve was implanted into the trifecta valve in a valve in valve procedure was reported.A more comprehensive assessment could not be performed as the device remains implanted and was not received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event or Problem Description
It was reported that on an unknown date a 21mm trifecta valve was implanted in the the aortic valve.On (b)(6) 2023, a 25mm navitor valve was implanted into the trifecta valve in a valve in valve procedure.The reason for the valve in valve procedure is unknown.The patient remained hemodynamically stable during the procedure.The patient was reported stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18041138
Report Number2135147-2023-04797
Device Sequence Number12781885
Product Code LWR
UDI-Device Identifier05414734052023
UDI-Public05414734052023
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
P100029
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 02/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberTF-21A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/10/2023
Supplement Date Received by Manufacturer11/20/2023
02/19/2024
Initial Report FDA Received Date10/31/2023
Supplement Report FDA Received Date12/08/2023
02/23/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient SexFemale
-
-